Skip to main content
Paul Yen, MD, Endocrinology, Durham, NC

PaulMYenMD

Endocrinology Durham, NC

Diabetes, Lipid Metabolism, Obesity, Thyroid

Professor / Director of Laboratory of Hormonal Regulation / Cardiovascular and Metabolic / Disorders Program/ Duke-NUS Medical School

Dr. Yen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yen's full profile

Already have an account?

  • Office

    Duke-NUS Medical School Cardiovascular and Metabolic Disorders Program
    8 College Road Level 8D Singapore, 589663 Singapore. Duke University SOM Dept Medicine
    Durham, NC 27708

Summary

  • 8 College Road, Level 8D14
    Singapore 589663
    SINGAPORE
  • Primary Appointment

    Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1989
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1982 - 1985
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1982
  • Amherst College
    Amherst CollegeB.A., Chemistry, 1978

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1989 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Abbott Clinical Thyroid Research Mentor Award (Endocrine Society), 2001
  • Boots Clinical Fellowship Mentor Award for outstanding thyroid research (Endocrine Society), 1993
  • New Investigator Award Nichols Institute (Endocrine Society), 1992

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Hepatic FOXO1 target genes are co-regulated by thyroid hormone via RICTOR deacetylation and MTORC2-AKT inhibition  
    Singh BK, Sinha RA, Zhou J, Tripathi M, Ohba K, Wang ME, Astapova I, Ghosh S, Hollenberg AN, Gauthier K, Yen PM, J Biol Chem, 1/1/2016
  • Caffeine stimulates hepatic lipid metabolism via autophagy-lysosomal pathway  
    Sinha RA, Farah BL, Singh BK, Siddique MM, Li Y, Wu Y, Ilkayeva OR, Gooding J, Ching J, Zhou J, Martinez L, Xie S, Bay BH, Summers SA, Newgard CB, Yen PM, Hepatology, 1/1/2014
  • Beta-Adrenergic agonist and antagonist regulation of hepatic autophagy  
    Farah BL, Sinha RA, Wu Y, Singh BK, Zhou J, Bay BH, Yen PM, PLOS One, 1/1/2014
  • Join now to see all

Press Mentions

  • A New Twist on an Old Hormone Leads to First Drug for a Type of Liver Disease
    A New Twist on an Old Hormone Leads to First Drug for a Type of Liver DiseaseAugust 12th, 2024

Professional Memberships

  • Member
  • Member
  • Asia Oceanic Thyroid Association
    Council Member
  • Endocrine and Metabolic Society of Singapore
    Member
  • Iodine Global Network (formerly International Council for the Control of Iodine Deficiency Disorders)
    Singapore Representative
  • World Thyroid Federation
    Representative for Asia

Other Languages

  • Chinese (Mandarin), French